Institutional Repository in Medical Sciences
(IRMS – Nicolae Testemițanu SUMPh)

Aspectele clinice şi de tratament ale purpurei trombocitopenice idiopatice

Show simple item record

dc.contributor.author Musteaţă, Larisa
dc.contributor.author Corcimaru, Ion
dc.contributor.author Robu, Maria
dc.contributor.author Musteaţă, Vasile
dc.contributor.author Oleinicova, Elena
dc.contributor.author Buruiană, Sanda
dc.contributor.author Avram, Oxana
dc.date.accessioned 2019-06-25T21:56:07Z
dc.date.available 2019-06-25T21:56:07Z
dc.date.issued 2012
dc.identifier.citation MUSTEAŢĂ, Larisa, CORCIMARU, Ion et al. Aspectele clinice şi de tratament ale purpurei trombocitopenice idiopatice. In: Anale ştiinţifice ale USMF “Nicolae Testemiţanu”. Ed. a 13-a. Chişinau: СEP Medicina, 2012, Vol. 3: Probleme actuale în medicina internă, pp.309-313. en_US
dc.identifier.uri http://repository.usmf.md/handle/20.500.12710/4903
dc.description Catedra Hematologie şi Oncologie a U.S.M.F. „N. Testemiţanu” (şeful catedrei – prof. univ., dr.hab.şt.med. I. Corcimaru), IMSP Institutul Oncologic (director – prof., dr.hab.şt.med. V. Cernat) en_US
dc.description.abstract The aspects of the clinical evolution, diagnosis and treatment of the idiopathic thrombocytopenic purpura were studied in 50 patients. It has been established that the disease developed mostly in young females. The hemorrhagic syndrome had the microcirculatory petechial-echymotic pattern. Although the direct clinico-hematologic response to the treatment with corticosteroid hormones was registered in 86% of patients, in all cases the platelets count decreased within the next 3 – 5 months up to the initial values. Splenectomy allowed to аchieve the recovery in 84% of patients. Particularităţile evoluţiei clinice, diagnosticului şi tratamentului purpurei trombocitopenice idiopatice au fost studiate la 50 pacienţi. A fost stabilit că maladia mai frecvent s-a dezvoltat la femei de vîrstă tînără. Sindromul hemoragic trombocitopenic a avut un caracter microcirculator peteşial-echimatos. Deşi răspunsul clinico-hematologic nemijlocit la tratamentul cu corticosteroizi a fost înregistrat la 86% de pacienţi, în toate cazurile peste 3 – 5 luni numărul trombocitar a scăzut pînă la valorile iniţiale. Splenectomia a permis de a obţine vindecare la 84% de pacienţi. en_US
dc.language.iso ro en_US
dc.publisher CEP "Medicina" en_US
dc.title Aspectele clinice şi de tratament ale purpurei trombocitopenice idiopatice en_US
dc.title.alternative Clinical and management aspects of the idiopathic thrombocytopenic purpura en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account

Statistics